Clin2
NCT03820492Possibly a fitRecruiting

Testing imaging tools to assess a narrowed left main artery

Coronary Stenosis

Part of Heart & circulation clinical trials.

This trial compares different heart scans to decide how serious a narrowing is in the left main coronary artery. It may help doctors choose the safest and most accurate way to manage that blockage during a heart catheter procedure.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
104 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are age 18 or older.
  • You have a narrowing in the left main artery (LM) that looks moderate (about 30% to 80% narrowed) on angiogram, or the angiogram is unclear.
  • You have no major additional blockages in the left front (LAD) or left side (LCX) arteries beyond what’s allowed (with some limited exceptions like certain branch or artery openings).
  • You have not had certain prior heart procedures for the left coronary system (no prior stent in the left system, no bypass surgery).
  • You can safely take the study medicines and contrast used during the procedure (no allergy/contraindication to heparin, iodine contrast, beta-blocker, nitroglycerin, or adenosine), and your kidneys are healthy enough for contrast.
  • You are able to provide consent and do not have pregnancy risk rules that can’t be met, and you’re not expected to have less than 1 year of life expectancy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05312164Recruiting
Study collects heart procedure measurements for coronary artery disease

This study helps collect measurement data during a heart catheter procedure when coronary disease is suspected. You may be eligible if you’re having a catheter-based evaluation and doctors plan to assess blood flow to determine how severe a new heart blockage is.

Palo Alto, California
NCT01341327Recruiting
Study of treatment choices for left main artery narrowing

This observational study looks at people with a significantly narrowed “left main” heart artery and records treatment decisions and follow-up outcomes. It may help doctors better understand which care approaches work best for this condition in real-world practice.

Shanghai
NCT05829889Recruiting
FFR test versus angiogram to guide left main heart treatment

This trial compares two ways to decide how to treat a narrowed “left main” coronary artery: a pressure-based test (FFR) versus standard X-ray imaging (angiography). It aims to see which approach better helps choose safe, appropriate treatment using a stent when appropriate.

Hong Kong
NCT06436092Recruiting
Stent treatment for left main coronary artery disease

This trial studies a new way to treat blockages in the left main coronary artery using a drug-coated stent. It aims to find out if a careful approach with a single stent and temporary side-branch support works well for people with heart disease.

Ichinomiya, Aichi-ken
NCT07159737Not yet recruiting
Comparing two ways to open the left main heart artery

This study compares two ways of treating a severe blockage in the left main heart artery, which is the main pipe bringing blood to the whole heart. One way uses a special medicated stent, and the other uses a two-stent approach or a medication-coated balloon to keep the branch open. The goal is to see which method works better for people with this high-risk condition.

NCT07308496Not yet recruiting
Comparing two imaging tests for guiding coronary artery disease treatment

This trial compares two non-invasive imaging tests to help doctors decide whether patients with narrowed heart arteries need stents or surgery. One test uses a CT scan, the other uses a standard angiogram, both measuring blood flow to guide treatment.

Hear when a new Coronary Stenosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.